Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?

The Lancet Respiratory Medicine

Volumn 3, Issue 8, 2015, Pages e26-

  Groenke, Lars ^a   Disse, Bernd ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE FUROATE; SALBUTAMOL; VILANTEROL; ANDROSTANE DERIVATIVE; BENZYL ALCOHOL DERIVATIVE; BRONCHODILATING AGENT; CHLOROBENZENE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DECISION MAKING; DISEASE EXACERBATION; EOSINOPHIL COUNT; EOSINOPHILIA; HUMAN; LETTER; POST HOC ANALYSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SPUTUM EOSINOPHILIA; TREATMENT RESPONSE; BLOOD; DRUG EFFECTS; EOSINOPHIL; FEMALE; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ANDROSTADIENES; BENZYL ALCOHOLS; BRONCHODILATOR AGENTS; CHLOROBENZENES; EOSINOPHILS; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84939454822     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00258-1     Document Type: Letter

References (6)

1. Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med 2015, 3:435-442.
2. Bafadhel M, McKenna S, Terry S, et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012, 186:48-55.
3. Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of COPD: identification of biological clusters and their biomarkers. Am J Respir Crit Care Med 2011, 184:662-671.
4. Price D, Rigazio A, Postma D, et al. Blood eosinophilia and the number of exacerbations in COPD patients. Eur Respir J 2014, 44(suppl). abstr 4416.
5. Liesker JJW, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HAM Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Respir Med 2011, 105:1853-1860.
6. Chanez P, Vignola AM, O'Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997, 155:1529-1534.